View Cart (0 items)

Pharmaceutical

FDA reveals details on generic drugs watchdog reorganization

July 29, 2014
The U.S. Food and Drug Administration (FDA) has announced details of its long-awaited reorganization of the Office of Generic Drugs (OGD).
Read More

Mylan Buys Abbott's Non-U.S. Generic Drugs Portfolio

July 22, 2014
The deal will cost an estimated $5.3 billion and involve more than 100 products in several key areas.
Read More

Salix Pharmaceuticals to merge with Cosmo subsidiary

July 16, 2014
U.S.-based Salix Pharmaceuticals Ltd. has announced plans to merge with a unit of Italian company Cosmo Pharmaceuticals, Cosmo Technologies Ltd.
Read More

Omnicare to pay $124 million to settle fraud allegations

June 30, 2014
Cincinnati-based Omnicare Inc. is to pay more than $124 million in a settlement with the U.S. Department of Justice for allegedly offering financial incentives to healthcare facilities.
Read More

US regulator to tighten scrutiny on potential drug delay deals

June 24, 2014
The U.S. Federal Trade Commission has announced plans to increase probes into pharmaceutical deals that potentially harm competition by delaying the launch of generic drugs on the market.
Read More

Merck to take over hepatitis C drug maker

June 16, 2014
American pharmaceutical giant Merck & Co. is planning to buy Idenix Pharmaceuticals Inc., a Massachusetts-based company specializing in developing treatment for hepatitis C.
Read More

Teva gets approval for generic version of pain reliever Celebrex

June 11, 2014
The U.S. Food and Drug Administration (FDA) has approved the first generic versions of pain relieving drug product Celebrex (celecoxib).
Read More

Hikma Pharmaceuticals to take over US generic injectables manufacturer

June 5, 2014
London-based multinational company Hikma Pharmaceuticals PLC has reached an asset acquisition agreement with Ben Venue Laboratories for the purchase of its U.S. generic injectables division, Bedford Laboratories, for $300 million.
Read More

US pharma major Abbott to pay $2.9 billion for Chile's CFR

June 3, 2014
U.S. pharmaceuticals and healthcare products major Abbott Laboratories has agreed to acquire Chile-based pharmaceutical firm CFR Pharmaceuticals SA in a deal worth $2.9 billion.
Read More

Sun Pharma's response to FDA import ban seen as 'inadequate'

May 27, 2014
According to the U.S. Food and Drug Administration, Sun Pharma has failed to take sufficient measures to correct the violations that led to the enforcement action.
Read More